A Phase IIIB, Observer-Blind, Randomized, Placebo-Controlled, Multi-Center Study to Assess the Safety and Immunogenicity of GSK Meningococcal Group B Vaccine and 13-valent Pneumococcal Vaccine when Administered Concomitantly with Routine Vaccines to Heal

Project: Other project

StatusActive
Effective start/end date7/9/187/8/20

Funding

  • Corixa Corporation: $6,346.15